These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22669433)

  • 21. Chronic Cannabis Use and Treatment Failure of Onabotulinum Toxin A for Chronic Migraine.
    Chan TLH; Zhang N
    Can J Neurol Sci; 2019 Nov; 46(6):785-786. PubMed ID: 31469061
    [No Abstract]   [Full Text] [Related]  

  • 22. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
    Bruloy E; Sinna R; Grolleau JL; Bout-Roumazeilles A; Berard E; Chaput B
    Plast Reconstr Surg; 2019 Jan; 143(1):239-250. PubMed ID: 30589800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin a in the subscapular muscle.
    Yelnik AP; Colle FM; Bonan IV
    Eur Neurol; 2003; 50(2):91-3. PubMed ID: 12944713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 25. Botulinum toxin type A for the treatment of migraine.
    Aurora S
    Expert Opin Pharmacother; 2006 Jun; 7(8):1085-95. PubMed ID: 16722818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute migraine treatment guideline.
    Marino C
    Ann Intern Med; 2003 Oct; 139(7):603; author reply 603-4. PubMed ID: 14530242
    [No Abstract]   [Full Text] [Related]  

  • 28. Botulinum toxin in clinical practice.
    Jankovic J
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):951-7. PubMed ID: 15201348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin. From poison to medical wonder.
    Mayo Clin Health Lett; 2006 Dec; 24(12):4-5. PubMed ID: 17310508
    [No Abstract]   [Full Text] [Related]  

  • 30. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Dis Mon; 2002 May; 48(5):323-35. PubMed ID: 12195263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin A for chronic migraine headaches: does it work and how?
    Cairns BE; Gazerani P
    Pain Manag; 2014; 4(6):377-80. PubMed ID: 25494688
    [No Abstract]   [Full Text] [Related]  

  • 33. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
    Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
    Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OnabotulinumtoxinA for treatment of chronic migraine: a response.
    Dodick DW; Turkel CC; Degryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF
    Headache; 2011 Jun; 51(6):1005-8. PubMed ID: 21592099
    [No Abstract]   [Full Text] [Related]  

  • 35. May migraine attack response to triptans be a predictor of the efficacy of Onabotulinum toxin-A prophylaxis?
    Lovati C; Giani L; Mariotti D Alessandro C; Tabaee Damavandi P; Mariani C; Pantoni L
    Neurol Sci; 2018 Jun; 39(Suppl 1):153-154. PubMed ID: 29904874
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
    Göbel H; Heinze A; Heinze-Kuhn K; Jost WH
    J Neurol; 2001 Apr; 248 Suppl 1():34-8. PubMed ID: 11357239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type a for chronic migraine.
    Ashkenazi A
    Curr Neurol Neurosci Rep; 2010 Mar; 10(2):140-6. PubMed ID: 20425239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A.
    Chen JJ; Swope DM
    J Clin Psychiatry; 2005 Feb; 66(2):267-8. PubMed ID: 15705018
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment options for ophthalmoplegic migraine.
    Granado L; Guillen G
    J Postgrad Med; 2009; 55(3):231; author reply 231-2. PubMed ID: 19884756
    [No Abstract]   [Full Text] [Related]  

  • 40. OnabotulinumtoxinA for the treatment of chronic migraine not quite there. .
    Torgovnick J
    Cephalalgia; 2011 Feb; 31(3):377; author reply 378-9. PubMed ID: 21098110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.